Accent Microcell, a company in the Pharmaceuticals industry, reported revenue of ₹175 crore and net profit of ₹31 crore for the September 2026 quarter.
Accent Microcell (NSE: ACCENTMIC-SM) closed at ₹584.85 on 20 Nov 2026, up 84.3% over the past year. Its market capitalisation is ₹1,403 crore and it trades at 24.6 times earnings.
Incorporated in 2012, Accent Microcell Ltd manufactures Pharmaceutical Excipients
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.